Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR17 | Q13304 | 5/20 | 0.71 |
| ▸ | FBP1 | P09467 | 1/20 | 0.49 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.47 |
| ▸ | APEX1 | P27695 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | CASP1 | P29466 | 1/20 | 0.46 |
| ▸ | CASP7 | P55210 | 1/20 | 0.46 |
| ▸ | HTR2A | P28223 | 1/20 | 0.45 |
| ▸ | HTR2C | P28335 | 1/20 | 0.45 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.44 |
| ▸ | KRAS | P01116 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21392019 | 0.85 | GPR17 (0.51) | GPR17APEX1KDM4EALDH1A1GAA | |
| SCHEMBL18509955 | 0.84 | HTR2A (0.63) | GPR17MCL1APEX1KDM4EALDH1A1 | |
| SCHEMBL18509465 | 0.83 | GPR17 (0.49) | GPR17APEX1KDM4EALDH1A1GAA | |
| SCHEMBL20119998 | 0.83 | GPR17 (0.49) | GPR17APEX1KDM4EALDH1A1GAA | |
| SCHEMBL29062863 | 0.83 | GPR17 (0.71) | GPR17FBP1MCL1KDM4EALDH1A1 | |
| SCHEMBL19872732 | 0.82 | GPR17 (0.49) | GPR17APEX1KDM4EALDH1A1GAA | |
| SCHEMBL4562210 | 0.82 | ALDH1A1 (0.57) | GPR17MCL1KDM4EALDH1A1HTR2A | |
| SCHEMBL19872789 | 0.81 | GPR17 (0.52) | GPR17FBP1APEX1KDM4EALDH1A1 | |
| SCHEMBL18509726 | 0.81 | SLC2A1 (0.55) | GPR17APEX1KDM4EALDH1A1GAA | |
| SCHEMBL18509959 | 0.81 | GPR17 (0.47) | GPR17APEX1KDM4EALDH1A1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11078467-B2 | Highly active self-sufficient nitration biocatalysts | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2021-08-03 | — | — | US | disclosed |
| US-20190292527-A1 | HIGHLY ACTIVE SELF-SUFFICIENT NITRATION BIOCATALYSTS | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2019-09-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11078467-B2 | Highly active self-sufficient nitration biocatalysts | POR, CYP4F3, CBR3 | GPR17 4789/4885FBP1 1041/4885MCL1 3164/4885 |
| US-20190292527-A1 | HIGHLY ACTIVE SELF-SUFFICIENT NITRATION BIOCATALYSTS | POR, CYP4F3, CBR3 | GPR17 4789/4885FBP1 1041/4885MCL1 3164/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.